Franklin, Tenn.-based Community Health Systems is shifting its focus towards ASCs in 2025, according to a quarterly earnings call published Oct. 24 by Seeking Alpha.
Leaders remarked on a positive conclusion to 2025, as CHS’ net operating revenues so far have exceeded $3 billion. CHS’ adjusted EBITDA for the third quarter was $376 million, compared with $347 million in the year prior, with a margin of 12.2%
CHS’ President and CEO Kavin Hammons also noted the continued investment in key service lines, citing the acquisition of several specialty practices, including robotic surgery programs, in several markets.
He also said that outpatient surgeries were down, which reflected “continued pressure on consumer demand for elective procedures” in CHS’ markets. In 2025, CHS has divested in seven hospitals as it continues to restructure its hospital portfolio in 2026.
“We’re still pursuing some divestitures [and] we’re in some early conversations,” Mr. Hammons said. “We don’t know how far those will go, but certainly we’re continuing to get some inbound interest. We are in some more advanced discussions on a couple deals which we think could be announced even later this year.”
Regarding ASCs specifically, Mr. Hammons said that the company is looking at expanding certain “access points,” which will focus heavily on outpatient care.
“As we kind of move through ’25 into 2026, more of our dollars will be focused on the access points, whether that’s urgent care, freestanding [emergency departments], ASCs, and so forth,” he said. “Those are lower dollar. We can do more of them for the same amount of capital.”
He added that CHS has been opening three to four freestanding EDs per year, has three ASCs opening before the end of 2025, and plans to open between six and eight ASCs in 2025.
